These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20215968)

  • 1. KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study.
    Iakoubova OA; Robertson M; Tong CH; Rowland CM; Catanese JJ; Blauw GJ; Jukema JW; Murphy MB; Devlin JJ; Ford I; Shepherd J
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):455-61. PubMed ID: 20215968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.
    Iakoubova OA; Sabatine MS; Rowland CM; Tong CH; Catanese JJ; Ranade K; Simonsen KL; Kirchgessner TG; Cannon CP; Devlin JJ; Braunwald E
    J Am Coll Cardiol; 2008 Jan; 51(4):449-55. PubMed ID: 18222355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.
    Shiffman D; Sabatine MS; Louie JZ; Kirchgessner TG; Iakoubova OA; Campos H; Devlin JJ; Sacks FM
    Am J Cardiol; 2010 May; 105(9):1300-5. PubMed ID: 20403483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.
    Williams P; Pendyala L; Superko R
    BMC Med Genet; 2011 Mar; 12():42. PubMed ID: 21435211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy.
    Li Y; Iakoubova OA; Shiffman D; Devlin JJ; Forrester JS; Superko HR
    Am J Cardiol; 2010 Oct; 106(7):994-8. PubMed ID: 20854963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies.
    Arsenault BJ; Boekholdt SM; Hovingh GK; Hyde CL; DeMicco DA; Chatterjee A; Barter P; Deedwania P; Waters DD; LaRosa JC; Pedersen TR; Kastelein JJ;
    Circ Cardiovasc Genet; 2012 Feb; 5(1):51-7. PubMed ID: 22135385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.
    Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
    Atherosclerosis; 2012 Feb; 220(2):456-62. PubMed ID: 22192511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
    Hopewell JC; Parish S; Clarke R; Armitage J; Bowman L; Hager J; Lathrop M; Collins R;
    J Am Coll Cardiol; 2011 May; 57(20):2000-7. PubMed ID: 21458191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect.
    Peng P; Lian J; Huang RS; Xu L; Huang Y; Ba Y; Yang X; Huang X; Dong C; Zhang L; Ye M; Zhou J; Duan S
    PLoS One; 2012; 7(12):e50126. PubMed ID: 23236363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.
    Shiffman D; Chasman DI; Zee RY; Iakoubova OA; Louie JZ; Devlin JJ; Ridker PM
    J Am Coll Cardiol; 2008 Jan; 51(4):444-8. PubMed ID: 18222354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
    Iakoubova OA; Tong CH; Rowland CM; Kirchgessner TG; Young BA; Arellano AR; Shiffman D; Sabatine MS; Campos H; Packard CJ; Pfeffer MA; White TJ; Braunwald E; Shepherd J; Devlin JJ; Sacks FM
    J Am Coll Cardiol; 2008 Jan; 51(4):435-43. PubMed ID: 18222353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.
    Ridker PM; MacFadyen JG; Glynn RJ; Chasman DI
    Circ Cardiovasc Genet; 2011 Jun; 4(3):312-7. PubMed ID: 21493817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients.
    Sabbagh M; Malek-Ahmadi M; Levenson I; Sparks DL
    J Alzheimers Dis; 2013; 33(1):111-6. PubMed ID: 22914592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies.
    Assimes TL; Hólm H; Kathiresan S; Reilly MP; Thorleifsson G; Voight BF; Erdmann J; Willenborg C; Vaidya D; Xie C; Patterson CC; Morgan TM; Burnett MS; Li M; Hlatky MA; Knowles JW; Thompson JR; Absher D; Iribarren C; Go A; Fortmann SP; Sidney S; Risch N; Tang H; Myers RM; Berger K; Stoll M; Shah SH; Thorgeirsson G; Andersen K; Havulinna AS; Herrera JE; Faraday N; Kim Y; Kral BG; Mathias RA; Ruczinski I; Suktitipat B; Wilson AF; Yanek LR; Becker LC; Linsel-Nitschke P; Lieb W; König IR; Hengstenberg C; Fischer M; Stark K; Reinhard W; Winogradow J; Grassl M; Grosshennig A; Preuss M; Schreiber S; Wichmann HE; Meisinger C; Yee J; Friedlander Y; Do R; Meigs JB; Williams G; Nathan DM; MacRae CA; Qu L; Wilensky RL; Matthai WH; Qasim AN; Hakonarson H; Pichard AD; Kent KM; Satler L; Lindsay JM; Waksman R; Knouff CW; Waterworth DM; Walker MC; Mooser VE; Marrugat J; Lucas G; Subirana I; Sala J; Ramos R; Martinelli N; Olivieri O; Trabetti E; Malerba G; Pignatti PF; Guiducci C; Mirel D; Parkin M; Hirschhorn JN; Asselta R; Duga S; Musunuru K; Daly MJ; Purcell S; Eifert S; Braund PS; Wright BJ; Balmforth AJ; Ball SG; ; ; ; Ouwehand WH; Deloukas P; Scholz M; Cambien F; Huge A; Scheffold T; Salomaa V; Girelli D; Granger CB; Peltonen L; McKeown PP; Altshuler D; Melander O; Devaney JM; Epstein SE; Rader DJ; Elosua R; Engert JC; Anand SS; Hall AS; Ziegler A; O'Donnell CJ; Spertus JA; Siscovick D; Schwartz SM; Becker D; Thorsteinsdottir U; Stefansson K; Schunkert H; Samani NJ; Quertermous T
    J Am Coll Cardiol; 2010 Nov; 56(19):1552-63. PubMed ID: 20933357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.
    Sabatine MS; Ploughman L; Simonsen KL; Iakoubova OA; Kirchgessner TG; Ranade K; Tsuchihashi Z; Zerba KE; Long DU; Tong CH; Packard CJ; Pfeffer MA; Devlin JJ; Shepherd J; Campos H; Sacks FM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):562-7. PubMed ID: 18174457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of KIF6 Polymorphism rs20455 on Coronary Heart Disease Risk and Effectiveness of Statin Therapy in 100 Patients from Southern Iran.
    Hamidizadeh L; Haji Hosseini Baghdad Abadi R; Babaee Baigi MA; Dastsooz H; Khazaei Nejhad A; Fardaei M
    Arch Iran Med; 2015 Oct; 18(10):683-7. PubMed ID: 26443250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in the KIF6 region and coronary event reduction from statin therapy.
    Li Y; Sabatine MS; Tong CH; Ford I; Kirchgessner TG; Packard CJ; Robertson M; Rowland CM; Bare LA; Shepherd J; Devlin JJ; Iakoubova OA
    Hum Genet; 2011 Jan; 129(1):17-23. PubMed ID: 20886236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Lloyd SM; Stott DJ; de Craen AJ; Kearney PM; Sattar N; Perry I; Packard CJ; Briggs A; Marchbank L; Comber H; Jukema JW; Westendorp RG; Trompet S; Buckley BM; Ford I
    PLoS One; 2013; 8(9):e72642. PubMed ID: 24023757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of targeted high-dose atorvastatin therapy following genotype testing in patients with acute coronary syndrome.
    Parthan A; Leahy KJ; O'Sullivan AK; Iakoubova OA; Bare LA; Devlin JJ; Weinstein MC
    Pharmacoeconomics; 2013 Jun; 31(6):519-31. PubMed ID: 23585310
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Iakoubova OA; Tong CH; Catanese J; Rowland CM; Luke MM; Tranquilli M; Elefteriades JA
    Aorta (Stamford); 2016 Jun; 4(3):83-90. PubMed ID: 28097184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.